Skip to main content
Fig. 1 | BMC Research Notes

Fig. 1

From: Bacteraemic urinary tract infections in a tertiary hospital in Japan: the epidemiology of community-acquired infections and the role of non-carbapenem therapy

Fig. 1

Schematic of patient enrolment. HA hospital-acquired, CA community-acquired, NHCA non-healthcare associated, UTI urinary tract infection, ESBL extended-spectrum beta-lactamase, ESBLPE extended-spectrum beta-lactamase-producing Enterobacteriaceae, CBP carbapenem, non-CBPBL non-carbapenem beta-lactam, PT piperacillin–tazobactam, CMZ cefmetazole

Back to article page